OBD — Oxford Biodynamics Share News
0.000.00%
- £9.30m
- £10.18m
- £0.64m
RCS - Oxford BioDynamics - OBD in New Report on NHS Prostate Cancer Screening
AnnouncementREG - Oxford BioDynamics - OBD and UEA develop test for Chronic Fatigue
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementRCS - Oxford BioDynamics - Study confirms clinical utility of EpiSwitch CiRT
AnnouncementREG - Oxford BioDynamics - Collaboration with Google Cloud
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementRCS - Oxford BioDynamics - GenomeWeb to host joint Agilent/OBD presentation
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementRCS - Oxford BioDynamics - Pfizer study on EpiSwitch biomarkers
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementREG - Oxford BioDynamics - Interim Results
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
AnnouncementRCS - Oxford BioDynamics - OBD’s Oxford Lab accredited by UKAS
AnnouncementREG - Oxford BioDynamics - Director/PDMR Shareholding
AnnouncementREG - Oxford BioDynamics - PDMR Dealing
AnnouncementREG - Oxford BioDynamics - Result of AGM
AnnouncementREG - Oxford BioDynamics - Board Changes
AnnouncementREG - Oxford BioDynamics - Holding(s) in Company
Announcement